ArticleMolecular and clinical oncology2018

Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.

Yasuomi Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.